Ximelagatran, an oral direct thrombin inhibitor, compared with current standard therapy for acute, symptomatic deep vein thrombosis, with or without pulmonary embolism: the THRIVE Treatment Study Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Wimperis, J
  • Fiessinger, JN
  • Huisman, MV
  • Davidson, BL
  • Bounameaux, H
  • Francis, CW
  • Eriksson, I
  • Lundstrom, T
  • Berkowitz, SD
  • Nystrom, P
  • Ginsberg, Jeffrey

publication date

  • April 1, 2004